BIOMAT Database Logo BIOMAT Database Logo

Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents. 2012

Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
School of Medical Engineering, Hefei University of Technology, Hefei 230009, PR China.

A series of resveratrol derivatives possessing curcumin moiety were synthesized and evaluated for their antiproliferative activity against three cancer cell lines including murine melanoma B16-F10, human hepatoma HepG2 and human lung carcinoma A549. Among them, compound C5 displayed the most potent in vitro antiproliferative activity against B16-F10 with IC(50) value of 0.71 μg/mL. Compound C5 also exhibited good tubulin polymerization inhibitory activity with IC(50) value of 1.45 μg/mL. Furthermore, docking simulation was carried out to position C5 into the tubulin-colchicine binding site to determine the probable binding mode.

UI MeSH Term Description Entries
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003474 Curcumin A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-,Curcumin Phytosome,Diferuloylmethane,Mervia,Turmeric Yellow,Phytosome, Curcumin,Yellow, Turmeric
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
November 2011, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
November 2010, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, Biological Activity Evaluation and Molecular Docking of Imidazole Derivatives Possessing Hydrazone Moiety.
June 2023, Chemistry & biodiversity,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents.
May 2012, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.
February 2012, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation and molecular modeling of imidazo[1,2-a]pyridine derivatives as potent antitubulin agents.
August 2017, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies.
June 2020, Bioorganic chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
July 2013, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
December 2010, Bioorganic & medicinal chemistry,
Ban-Feng Ruan, and Xiang Lu, and Ting-Ting Li, and Jian-Feng Tang, and Yao Wei, and Xiao-Liang Wang, and Shi-Li Zheng, and Ri-Sheng Yao, and Hai-Liang Zhu
Synthesis, biological evaluation and docking studies of methylene bearing cyanopyrimidine derivatives possessing a hydrazone moiety as potent Lysine specific demethylase-1 (LSD1) inhibitors: A promising anticancer agents.
September 2022, Bioorganic chemistry,
Copied contents to your clipboard!